I can understand that any buyer/partner may not pay so much for "potential" since Cytodyn has no approvals and no revenue. But to go along with the talk of FDA "intentionally slow playing" LL approval, some say corruption, whatever, I'd expect that a Merck or JNJ buyout, would be prefaced by their.....
a) pre-knowledge of the true fact that LL works against cancer, HIV and cv19 (not potential)
b) pre-knowledge of the fact that the FDA will approve, after the partnership or buyout is finalized (not potential approval) "Oh, you're with our pals now, OK!"

Billion Dollar Corporations Have Billion Dollar Power, Knowledge, Influence